Cargando…
Aberrant HMGA2 Expression Sustains Genome Instability That Promotes Metastasis and Therapeutic Resistance in Colorectal Cancer
SIMPLE SUMMARY: Despite recent advances in early diagnostic and therapeutic strategies, colorectal cancer remains one of the most diagnosed and lethal cancers worldwide. Further, several patients are diagnosed at late stages with metastatic disease, ultimately limiting their therapeutic options. To...
Autores principales: | Campos Gudiño, Rubi, McManus, Kirk J., Hombach-Klonisch, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046046/ https://www.ncbi.nlm.nih.gov/pubmed/36980621 http://dx.doi.org/10.3390/cancers15061735 |
Ejemplares similares
-
Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling
por: Gaudreau-Lapierre, Antoine, et al.
Publicado: (2023) -
A Comprehensive Assessment of Genetic and Epigenetic Alterations Identifies Frequent Variations Impacting Six Prototypic SCF Complex Members
por: Campos Gudiño, Rubi, et al.
Publicado: (2021) -
HMGA2 as a functional antagonist of PARP1 inhibitors in tumor cells
por: Hombach‐Klonisch, Sabine, et al.
Publicado: (2018) -
Characterizing Microsatellite Instability and Chromosome Instability in Interval Colorectal Cancers
por: Cisyk, Amy L., et al.
Publicado: (2018) -
Reduced SKP1 Expression Induces Chromosome Instability through Aberrant Cyclin E1 Protein Turnover
por: Thompson, Laura L., et al.
Publicado: (2020)